Cerenome, Inc. (CNSY) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-19.8%

$1.37

vs $1.71 price

Levered DCF

-$1.09

After debt service

Piotroski score

2 / 9

Weak

Altman Z-score

-56.95

Distress zone

Rating

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-0.56×	-0.08×	-0×	-0×	-0×	-0×	-0×	-0×
P/B	3.15×	-0.12×	-0×	0×	0×	0×	0×	0×
P/S	2.42×	0.18×	0×	0×	0×	0×	0×	0×
EV / EBITDA	-0.25×	-0.52×	0.36×	0.65×	0.94×	0.16×	10.49×	-1.36×
Gross margin	91.5%	85.4%	-97.2%	-217.9%	0.0%	-791.1%	100.0%	61.5%
Operating margin	-293.5%	-252.3%	-271.1%	-8800.0%	0.0%	-3163.0%	-52.3%	-293.7%
Net margin	-429.4%	-222.8%	-271.0%	-9051.3%	0.0%	-2719.8%	-155.6%	-423.5%
Current ratio	1.23×	0.34×	0.92×	1.84×	3.36×	1.07×	1.37×	0.55×
Debt / equity	0.21×	-0.38×	-3.1×	0.89×	0.65×	2.31×	10.32×	2.72×
Interest coverage	-4.24×	-3.95×	-33.72×	-27.72×	-13.4×	-8.66×	-1.97×	-4.56×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-560.2%	145.0%	987.8%	-314.6%	-123.7%	-271.9%	-938.5%	-241.8%
Return on invested capital	-317.6%	263.3%	-280.0%	-142.4%	-70.1%	-95.5%	-18.2%	-42.5%
Return on assets	-137.1%	-195.7%	-116.9%	-84.9%	-61.0%	-68.1%	-46.9%	-52.7%
Free cash flow yield	-165.4%	-994.7%	-2549676.7%	-4843386.2%	-8043209.9%	-18368312.8%	-39960517.2%	-644872655.2%
Earnings yield	-177.6%	-1206.4%	-2609445.4%	-7151675.5%	-10338734.6%	-16956790.1%	-72836120.9%	-672887440.2%
Enterprise value	$4.7M	$4.4M	-$4.4M	-$12.4M	-$11.4M	-$1.3M	-$5.6M	$8.9M
Net debt / EBITDA	0.43×	-0.39×	0.36×	0.65×	0.94×	0.16×	10.49×	-1.36×
Cash conversion cycle (days)	-2,687	-4,023	-179	-4,288	-14,440	-36	68	-167